Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.45 USD | -1.36% | +5.07% | -3.33% |
Business Summary
Number of employees: 13
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Small Molecule Therapeutics
100.0
%
| 0 | nan % | 1 | 100.0 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | nan % | 1 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Yuichi Iwaki
FOU | Founder | 74 | 00-09-25 |
Jason Kruger
DFI | Director of Finance/CFO | 47 | 22-06-15 |
Kazuko Matsuda
CTO | Chief Tech/Sci/R&D Officer | 58 | 09-12-31 |
Geoffrey O'Brien
IRC | Investor Relations Contact | 55 | 09-05-31 |
David Crean
PRN | Corporate Officer/Principal | 59 | 21-04-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Hideki Nagao
BRD | Director/Board Member | 67 | 04-08-31 |
Yuichi Iwaki
FOU | Founder | 74 | 00-09-25 |
Carolyn Beaver
BRD | Director/Board Member | 66 | 20-10-19 |
Kazuko Matsuda
CTO | Chief Tech/Sci/R&D Officer | 58 | 09-12-31 |
Nicole Lemerond
BRD | Director/Board Member | 49 | 23-08-03 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 49,046,246 | 47,790,540 ( 97.44 %) | 0 | 97.44 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.33% | 72.1M | |
+2.73% | 108B | |
+9.59% | 104B | |
+6.58% | 23.66B | |
-12.59% | 22.1B | |
-3.29% | 19.71B | |
-35.36% | 18.2B | |
-13.29% | 16.19B | |
+4.68% | 13.72B | |
+34.25% | 12.22B |
- Stock
- Equities
- Stock MediciNova, Inc. - Nasdaq
- Company MediciNova, Inc.